PT1121127E - Composicoes farmaceuticas orais contendo buprenorfina - Google Patents
Composicoes farmaceuticas orais contendo buprenorfinaInfo
- Publication number
- PT1121127E PT1121127E PT99950690T PT99950690T PT1121127E PT 1121127 E PT1121127 E PT 1121127E PT 99950690 T PT99950690 T PT 99950690T PT 99950690 T PT99950690 T PT 99950690T PT 1121127 E PT1121127 E PT 1121127E
- Authority
- PT
- Portugal
- Prior art keywords
- orais
- buprenorfin
- pharmaceutical compositions
- pharmaceutically acceptable
- pharmaceutical composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 abstract 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998MI002222A IT1302682B1 (it) | 1998-10-16 | 1998-10-16 | Composizioni farmaceutiche orali contenenti buprenorfina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1121127E true PT1121127E (pt) | 2005-03-31 |
Family
ID=11380880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99950690T PT1121127E (pt) | 1998-10-16 | 1999-10-11 | Composicoes farmaceuticas orais contendo buprenorfina |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6365596B1 (it) |
| EP (1) | EP1121127B1 (it) |
| JP (1) | JP2002527480A (it) |
| AT (1) | ATE287264T1 (it) |
| AU (1) | AU752449B2 (it) |
| CA (1) | CA2347195C (it) |
| DE (1) | DE69923336T2 (it) |
| DK (1) | DK1121127T3 (it) |
| ES (1) | ES2237165T3 (it) |
| HU (1) | HU226166B1 (it) |
| IT (1) | IT1302682B1 (it) |
| NZ (1) | NZ511085A (it) |
| PT (1) | PT1121127E (it) |
| SI (1) | SI1121127T1 (it) |
| WO (1) | WO2000023079A1 (it) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1368023B1 (de) * | 2001-02-16 | 2005-12-28 | Grünenthal GmbH | Verwendung von buprenorphin zur therapie der harninkontinenz |
| US20140271788A1 (en) | 2013-03-15 | 2014-09-18 | Monosol Rx, Llc | Sublingual and buccal film compositions |
| NZ550320A (en) | 2004-04-15 | 2010-02-26 | Chiasma Inc | Compositions capable of facilitating penetration across a biological barrier |
| DE602004017514D1 (de) * | 2004-06-02 | 2008-12-11 | Galephar M F | Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon |
| US20070117828A1 (en) * | 2005-11-21 | 2007-05-24 | Schering-Plough Animal Health Corp. | Pharmaceutical compositions |
| EP1897543A1 (en) | 2006-08-30 | 2008-03-12 | Euro-Celtique S.A. | Buprenorphine- wafer for drug substitution therapy |
| US20090270438A1 (en) * | 2006-10-18 | 2009-10-29 | Clive Booles | Novel compositions and formulations |
| US20090082383A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched buprenorphine |
| BRPI0918652B1 (pt) | 2008-09-17 | 2021-10-19 | Chiasma, Inc. | Composição farmacêutica compreendendo um meio hidrofóbico e uma forma sólida que compreende polipeptídeo e sal de ácido graxo de cadeia média, processo de produção da mesma e forma de dosagem oral |
| GB2469792A (en) * | 2009-04-23 | 2010-11-03 | Calvin John Ross | Oil-based pharmaceutical formulation for sublingual delivery |
| SI2915525T1 (sl) | 2011-09-19 | 2022-01-31 | Orexo Ab | Sublingvalne tablete, odporne proti zlorabi, ki vsebujejo buprenorfin in nalokson |
| US9918981B2 (en) | 2013-09-10 | 2018-03-20 | Insys Development Company, Inc. | Liquid buprenorphine formulations |
| US9867818B2 (en) | 2013-09-10 | 2018-01-16 | Insys Development Company, Inc. | Sublingual buprenorphine spray |
| US9839611B2 (en) | 2013-09-10 | 2017-12-12 | Insys Development Company, Inc. | Sublingual buprenorphine spray |
| WO2015038327A1 (en) | 2013-09-10 | 2015-03-19 | Insys Pharma, Inc. | Sublingual buprenorphine spray |
| US10617686B2 (en) | 2014-07-08 | 2020-04-14 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
| CA2954370A1 (en) | 2014-07-08 | 2016-01-14 | Insys Pharma, Inc. | Sublingual naloxone spray |
| US10722510B2 (en) | 2014-07-08 | 2020-07-28 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
| HUE071943T2 (hu) | 2015-02-03 | 2025-10-28 | Amryt Endo Inc | Akromegália kezelése oktreotid orális alkalmazásával |
| AU2019209416A1 (en) | 2018-01-22 | 2020-07-30 | Foresee Pharmaceuticals Co., Ltd. | Pharmaceutical composition for sustained release delivery of buprenorphine |
| US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4605671A (en) | 1984-09-28 | 1986-08-12 | American Home Products Corporation | Parenteral formulation |
| JPH03275622A (ja) * | 1990-03-26 | 1991-12-06 | Teisan Seiyaku Kk | マレイン酸トリメブチンを含有する経口固形製剤 |
| JPH08295637A (ja) * | 1995-04-27 | 1996-11-12 | Green Cross Corp:The | 口腔部局所投与剤 |
| AU2059297A (en) * | 1996-03-12 | 1997-10-01 | Alza Corporation | Composition and dosage form comprising opioid antagonist |
| JP3687025B2 (ja) * | 1998-06-04 | 2005-08-24 | 東和薬品株式会社 | 安定なマレイン酸エナラプリル錠剤 |
-
1998
- 1998-10-16 IT IT1998MI002222A patent/IT1302682B1/it active IP Right Grant
-
1999
- 1999-10-11 WO PCT/EP1999/007595 patent/WO2000023079A1/en not_active Ceased
- 1999-10-11 JP JP2000576853A patent/JP2002527480A/ja active Pending
- 1999-10-11 CA CA002347195A patent/CA2347195C/en not_active Expired - Lifetime
- 1999-10-11 HU HU0103924A patent/HU226166B1/hu not_active IP Right Cessation
- 1999-10-11 SI SI9930736T patent/SI1121127T1/xx unknown
- 1999-10-11 DE DE69923336T patent/DE69923336T2/de not_active Expired - Lifetime
- 1999-10-11 PT PT99950690T patent/PT1121127E/pt unknown
- 1999-10-11 AT AT99950690T patent/ATE287264T1/de active
- 1999-10-11 NZ NZ511085A patent/NZ511085A/xx not_active IP Right Cessation
- 1999-10-11 US US09/807,216 patent/US6365596B1/en not_active Expired - Lifetime
- 1999-10-11 AU AU63371/99A patent/AU752449B2/en not_active Ceased
- 1999-10-11 ES ES99950690T patent/ES2237165T3/es not_active Expired - Lifetime
- 1999-10-11 EP EP99950690A patent/EP1121127B1/en not_active Expired - Lifetime
- 1999-10-11 DK DK99950690T patent/DK1121127T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DE69923336D1 (de) | 2005-02-24 |
| ITMI982222A1 (it) | 2000-04-16 |
| EP1121127B1 (en) | 2005-01-19 |
| US6365596B1 (en) | 2002-04-02 |
| ITMI982222A0 (it) | 1998-10-16 |
| NZ511085A (en) | 2002-10-25 |
| WO2000023079A1 (en) | 2000-04-27 |
| AU6337199A (en) | 2000-05-08 |
| HU226166B1 (en) | 2008-05-28 |
| HUP0103924A3 (en) | 2003-05-28 |
| SI1121127T1 (en) | 2005-06-30 |
| CA2347195A1 (en) | 2000-04-27 |
| HUP0103924A2 (hu) | 2002-02-28 |
| ATE287264T1 (de) | 2005-02-15 |
| DK1121127T3 (da) | 2005-05-02 |
| JP2002527480A (ja) | 2002-08-27 |
| EP1121127A1 (en) | 2001-08-08 |
| IT1302682B1 (it) | 2000-09-29 |
| AU752449B2 (en) | 2002-09-19 |
| DE69923336T2 (de) | 2005-05-25 |
| ES2237165T3 (es) | 2005-07-16 |
| CA2347195C (en) | 2008-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1121127E (pt) | Composicoes farmaceuticas orais contendo buprenorfina | |
| NO2025027I1 (no) | Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget. | |
| BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
| AU2003303458A1 (en) | Ampholytic copolymer and use thereof | |
| TW200633716A (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
| EP2308479A3 (en) | Compounds and compositions for delivering active agents | |
| ZA200410211B (en) | Quinuclidine derivatives and pharmaceutical compositions containing the same. | |
| IL164440A0 (en) | New pharmaceutical composition containing fibanserin polymorph a | |
| IT1320080B1 (it) | Composizione per uso farmaceutico o dietetico. | |
| AU2002309038A1 (en) | Compositions for transmucosal administration containing coenzyme Q as the active ingredient | |
| PL348419A1 (en) | Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient | |
| SE9802208D0 (sv) | Novel compounds | |
| TW200509992A (en) | Dosage form containing pantoprazole as active ingredient | |
| ATE268175T1 (de) | Decursin-enthaltende pharmazeutische zusammensetzungen | |
| HUP0303673A3 (en) | Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient | |
| TW200507838A (en) | Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator | |
| TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
| AU4317500A (en) | Antibiral compositions containing phorbol derivatives as the main active ingredient | |
| SE9802209D0 (sv) | Novel compounds | |
| ATE412404T1 (de) | Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon | |
| WO2003061572A3 (en) | Anti-inflammatory formulations | |
| EP1273301A3 (en) | Pharmaceutical preparations based on active ingredients susceptible to illict administration | |
| EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение | |
| MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. | |
| WO2002004012A8 (en) | Anhydrous pharmaceutical composition of vancomycin for topical use |